title: Dissection of antibody specificities induced by yellow fever vaccination.
abstract: The live attenuated yellow fever (YF) vaccine has an excellent record of efficacy and one dose provides long-lasting immunity, which in many cases may last a lifetime. Vaccination stimulates strong innate and adaptive immune responses, and neutralizing antibodies are considered to be the major effectors that correlate with protection from disease. Similar to other flaviviruses, such antibodies are primarily induced by the viral envelope protein E, which consists of three distinct domains (DI, II, and III) and is presented at the surface of mature flavivirions in an icosahedral arrangement. In general, the dominance and individual variation of antibodies to different domains of viral surface proteins and their impact on neutralizing activity are aspects of humoral immunity that are not well understood. To gain insight into these phenomena, we established a platform of immunoassays using recombinant proteins and protein domains that allowed us to dissect and quantify fine specificities of the polyclonal antibody response after YF vaccination in a panel of 51 vaccinees as well as determine their contribution to virus neutralization by serum depletion analyses. Our data revealed a high degree of individual variation in antibody specificities present in post-vaccination sera and differences in the contribution of different antibody subsets to virus neutralization. Irrespective of individual variation, a substantial proportion of neutralizing activity appeared to be due to antibodies directed to complex quaternary epitopes displayed on the virion surface only but not on monomeric E. On the other hand, DIII-specific antibodies (presumed to have the highest neutralizing activity) as well as broadly flavivirus cross-reactive antibodies were absent or present at very low titers. These data provide new information on the fine specificity as well as variability of antibody responses after YF vaccination that are consistent with a strong influence of individual-specific factors on immunodominance in humoral immune responses.
authors.affiliation: Department of Virology, Medical University of Vienna, Vienna, Austria.
authors.forename: Oksana
authors.initials: O
authors.lastname: Vratskikh
authors.forename: Karin
authors.initials: K
authors.lastname: Stiasny
authors.forename: Jürgen
authors.initials: J
authors.lastname: Zlatkovic
authors.forename: Georgios
authors.initials: G
authors.lastname: Tsouchnikas
authors.forename: Johanna
authors.initials: J
authors.lastname: Jarmer
authors.forename: Urs
authors.initials: U
authors.lastname: Karrer
authors.forename: Michael
authors.initials: M
authors.lastname: Roggendorf
authors.forename: Hedwig
authors.initials: H
authors.lastname: Roggendorf
authors.forename: Regina
authors.initials: R
authors.lastname: Allwinn
authors.forename: Franz X
authors.initials: FX
authors.lastname: Heinz
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D002460:Cell Line; D006224:Cricetinae; D003429:Cross Reactions / Q000276:immunology; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects* / Q000276:immunology; D051379:Mice; D014611:Vaccination; D015004:Yellow Fever / Q000276:immunology* / Q000517:prevention & control; D022341:Yellow Fever Vaccine / Q000276:immunology* / Q000494:pharmacology
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D022341:Yellow Fever Vaccine